Clinical-CFD Markers of Type-2 Diabetes
Funder: Good Hope Hospital (Heart of England NHS Foundation)Duration: October 2013 - May 2016
Initial CFD models of flow from UltraSound data for low-cost non-invasive method of assessing cardiovascular risk
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Mark Atherton (Principal investigator)
E: mark.atherton@brunel.ac.uk
|
mark.atherton@brunel.ac.uk |
Outputs
Konig, CS., Atherton, M., Rogers, N., Gomm, C., Bailey, C., Strange, RC., et al. (2015) 'The need for a marker predicting benefit following cardiovascular disease risk reduction treatment'. [Poster] Exhibited at. Ticagrelor Science Conference